Albuterol NDC 70710-1062

NDC codes

FDA NDC Directory

Product NDC (as listed)70710-1062Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70710-1062Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70710-1062-1	70710106201	100 TABLET in 1 BOTTLE (70710-1062-1)Marketed from Oct 23, 2020
70710-1062-5	70710106205	500 TABLET in 1 BOTTLE (70710-1062-5)Marketed from Oct 23, 2020

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Albuterol
Generic name (nonproprietary): albuterol
Active ingredients: Albuterol sulfate — 4 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Zydus Pharmaceuticals USA Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 208884
Marketing start: Oct 23, 2020
Listing expires: Dec 31, 2026
Other FDA classes: Adrenergic beta2-Agonists (Mechanism)
Identifiers: Product ID 70710-1062_1d5b3219-efd5-4842-9b6e-2ea1874d0d4dSPL ID 1d5b3219-efd5-4842-9b6e-2ea1874d0d4dSPL set ID c3fa0068-fd12-45de-818e-e929fb45ba05RxCUI 197316, 197318UNII 021SEF3731
Pharmacologic class: beta2-Adrenergic Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470710106201 followed by a unit qualifier and the quantity

Package 70710-1062-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 21, 2023.

Indications (excerpt from the label)

INDICATIONS AND USAGE Albuterol tablets, USP are indicated for the relief of bronchospasm in adults and children 6 years of age and older with reversible obstructive airway disease.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 208884

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 208884
Product	Strength	Form · route	Labeler	Product NDC
Albuterol	Albuterol sulfate 4 mg/1	TabletOral	Zydus Lifesciences Limited	70771-1512
Albuterol	Albuterol sulfate 2 mg/1	TabletOral	Zydus Lifesciences Limited	70771-1511
Albuterol	Albuterol sulfate 2 mg/1	TabletOral	Zydus Pharmaceuticals USA Inc.	70710-1061